SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-021960
Filing Date
2016-12-09
Accepted
2016-12-09 16:27:31
Documents
1
Period of Report
2016-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148131883731497.html 4  
1 FORM 4 wf-form4_148131883731497.xml 4 3984
  Complete submission text file 0001628280-16-021960.txt   5449
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 53 FRONTAGE ROAD, SUITE 301 PERRYVILLE III CORPORATE PARK HAMPTON NJ 08827
Business Address
Dekker Martin (Reporting) CIK: 0001643049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 162044367